dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:23:52Z
dc.date.accessioned2022-10-05T18:16:07Z
dc.date.available2014-05-27T11:23:52Z
dc.date.available2022-10-05T18:16:07Z
dc.date.created2014-05-27T11:23:52Z
dc.date.issued2009-03-01
dc.identifierJournal of oral science, v. 51, n. 1, p. 117-121, 2009.
dc.identifier1343-4934
dc.identifierhttp://hdl.handle.net/11449/70946
dc.identifier10.2334/josnusd.51.117
dc.identifier2-s2.0-68949105928
dc.identifier2-s2.0-68949105928.pdf
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3920197
dc.description.abstractThe potential for malignant transformation of oral lichen planus is still controversial. The expression of proteins related to cell proliferation and apoptosis in oral lichen planus and epithelial dysplasia was analyzed to evaluate the true potential for malignant transformation of this disease. Twenty-four cases of each lesion were subjected to the streptoavidin-biotin technique for identifying the immunohistochemical expression of PCNA, p53, bax, and bcl-2 proteins. Of the 24 cases of oral lichen planus, 14 (58.33%) were positive for PCNA, 10 (41.67%) for p53, 4 (16.67%) for bcl-2 and 12 (50%) for bax, whereas of the 24 cases of epithelial dysplasia, 20 (83.33%) were positive for PCNA, 10 (41.67%) for p53, 6 (25%) for bcl-2, and 20 (83.33%) for bax. Chi-squared test showed no statistically significant differences between the expression of p53 and bcl-2 in oral lichen planus and epithelial dysplasia, regardless of the grade (P > 0.05). However, the expression of PCNA and bax was significantly increased in epithelial dysplasia (P < 0.05). The results of this study showed that alterations in expression of these proteins are observed in oral lichen planus and epithelial dysplasia, suggesting the potential for malignant transformation in both lesions.
dc.languageeng
dc.relationJournal of oral science
dc.relation0.853
dc.relation0,397
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectBAX protein, human
dc.subjectcoloring agent
dc.subjectcycline
dc.subjectdiagnostic agent
dc.subjectprotein Bax
dc.subjectprotein bcl 2
dc.subjectprotein p53
dc.subjectapoptosis
dc.subjectcell proliferation
dc.subjectcell transformation
dc.subjecthuman
dc.subjectimmunohistochemistry
dc.subjectlichen planus
dc.subjectmouth tumor
dc.subjectpalatine tonsil
dc.subjectpathology
dc.subjectprecancer
dc.subjectsquamous cell carcinoma
dc.subjectApoptosis
dc.subjectbcl-2-Associated X Protein
dc.subjectCarcinoma, Squamous Cell
dc.subjectCell Proliferation
dc.subjectCell Transformation, Neoplastic
dc.subjectColoring Agents
dc.subjectHumans
dc.subjectImmunohistochemistry
dc.subjectLichen Planus, Oral
dc.subjectMouth Neoplasms
dc.subjectPalatine Tonsil
dc.subjectPrecancerous Conditions
dc.subjectProliferating Cell Nuclear Antigen
dc.subjectProto-Oncogene Proteins c-bcl-2
dc.subjectTumor Suppressor Protein p53
dc.titleImmunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia.
dc.typeArtigo


Este ítem pertenece a la siguiente institución